CA2078019C - Substance or composition and uses thereof - Google Patents

Substance or composition and uses thereof Download PDF

Info

Publication number
CA2078019C
CA2078019C CA002078019A CA2078019A CA2078019C CA 2078019 C CA2078019 C CA 2078019C CA 002078019 A CA002078019 A CA 002078019A CA 2078019 A CA2078019 A CA 2078019A CA 2078019 C CA2078019 C CA 2078019C
Authority
CA
Canada
Prior art keywords
methionine
vitamin
mass
ratio
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002078019A
Other languages
English (en)
French (fr)
Other versions
CA2078019A1 (en
Inventor
Siegbert Heinrich Bissbort
Henry John Davis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2078019A1 publication Critical patent/CA2078019A1/en
Application granted granted Critical
Publication of CA2078019C publication Critical patent/CA2078019C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002078019A 1991-09-13 1992-09-11 Substance or composition and uses thereof Expired - Fee Related CA2078019C (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
ZA91/7333 1991-09-13
ZA917333 1991-09-13
ZA917334 1991-09-13
ZA91/7334 1991-09-13
ZA923667 1992-05-20
ZA92/3667 1992-05-20

Publications (2)

Publication Number Publication Date
CA2078019A1 CA2078019A1 (en) 1993-03-14
CA2078019C true CA2078019C (en) 2002-08-27

Family

ID=27420971

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002078019A Expired - Fee Related CA2078019C (en) 1991-09-13 1992-09-11 Substance or composition and uses thereof

Country Status (8)

Country Link
US (1) US5545670A (US06312121-20011106-C00033.png)
EP (1) EP0532369B1 (US06312121-20011106-C00033.png)
AP (1) AP387A (US06312121-20011106-C00033.png)
AT (1) ATE244005T1 (US06312121-20011106-C00033.png)
AU (1) AU666490B2 (US06312121-20011106-C00033.png)
CA (1) CA2078019C (US06312121-20011106-C00033.png)
DE (1) DE69233115T2 (US06312121-20011106-C00033.png)
IL (1) IL103152A (US06312121-20011106-C00033.png)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19504936C1 (de) * 1995-02-15 1996-05-15 Woerwag Pharma Gmbh Arzneimittel auf der Grundlage von Magnesiumchlorid
DE19521314A1 (de) * 1995-06-12 1996-12-19 Max Planck Gesellschaft Adhärenzgen aus Helicobacter pylori und davon codiertes Polypeptid
US6265391B1 (en) 1995-10-17 2001-07-24 Upsher-Smith Laboratories, Inc. Method for preventing peripheral nerve damage
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US6008221A (en) * 1996-11-06 1999-12-28 Bristol-Myers Squibb Company Method for treating Alzheimer's disease with folic acid
SE9604844D0 (sv) * 1996-12-30 1996-12-30 Carl Gerhard Gottfries Medel för terapeutisk behandling av fibromyalgi och kroniskt trötthetssyndrom
US6537997B1 (en) 1997-02-18 2003-03-25 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US6399622B1 (en) 1997-02-18 2002-06-04 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US5872123A (en) 1997-02-18 1999-02-16 Lerner; A. Martin Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US5900420A (en) * 1997-06-19 1999-05-04 Cole; William L. Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
US5770217A (en) * 1997-07-02 1998-06-23 Atlatl, Inc. Dietary supplement for hematological, immune and appetite enhancement
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
DE69805305T2 (de) * 1997-08-21 2002-12-05 Gerolymatos P N Sa Verwendung von phanquinon zur behandlung von alzheimer's krankheit
US5993866A (en) * 1997-09-12 1999-11-30 Shapira; Niva Process of making food products having reduced methionine ratios
US6096317A (en) * 1998-01-13 2000-08-01 Rexall Sundown St. John's Wort and methyl donor composition and uses thereof
EP0951842B1 (en) 1999-01-20 2002-12-04 N.V. Nutricia Infant formula
US6274170B1 (en) 1999-02-18 2001-08-14 Richard Heibel Compounds for cardiovascular treatment comprising multi-vitamin and anti-platelet aggregating agents and methods for making and using the same
GB9906740D0 (en) * 1999-03-23 1999-05-19 Kilgowan Limited Oral combinations of hydroxocobalamin and folic acid
US8642581B1 (en) 2000-02-11 2014-02-04 Brian D. Halevie-Goldman Compositions and methods for the production of S-adenosylmethionine within the body
US7033534B2 (en) * 2001-10-09 2006-04-25 3M Innovative Properties Company Method for forming microstructures on a substrate using a mold
US7176492B2 (en) * 2001-10-09 2007-02-13 3M Innovative Properties Company Method for forming ceramic microstructures on a substrate using a mold and articles formed by the method
US6585998B2 (en) 2001-11-13 2003-07-01 Rudolph Cartwright Nutraceutical composition
US20030224401A1 (en) * 2002-02-19 2003-12-04 The Regents Of The University Of California Proteins for helicobacter diagnosis
ATE457726T1 (de) * 2002-06-19 2010-03-15 Nutricia Nv Nahrungs- oder pharmazeutische zusammensetzungen zur erhöhung der creatin-antwort von organismen
AU2003247225A1 (en) * 2002-06-19 2004-01-06 N.V. Nutricia Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
US20040062821A1 (en) * 2002-10-01 2004-04-01 Elena Avram Administration of therapeutic compositions for treating fatigue
ITTO20040329A1 (it) * 2004-05-18 2004-08-18 Franco Deraco Uso di una composizione farmaceutica per il trattamento di patologie derivate da infezione da herpes virus, papilloma virus,hepatitis virus, nevralgie di origine virale, displasie di origine virale, displasie di origine virale, forme virali per immun
US8877201B2 (en) 2007-10-25 2014-11-04 Wake Forest University Health Sciences Bordetella outer-membrane protein antigens and methods of making and using the same
US20140100238A1 (en) 2012-10-04 2014-04-10 Ohio State University Method of diagnosing and treating epstein barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients
FR3024019B1 (fr) * 2014-07-28 2017-11-24 Yvan Erbs Complement alimentaire pour ameliorer le fonctionnement des cellules vivantes et procede associe

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2126134A1 (en) * 1971-02-26 1972-10-06 Ates Ibrahim Cyclophosphamide/magnesium compsns - with enhanced cytostatic activity
US4237118A (en) * 1972-03-06 1980-12-02 Howard Alan N Dietary supplement and dietary methods employing said supplement for the treatment of obesity
CH603069A5 (US06312121-20011106-C00033.png) * 1974-11-21 1978-08-15 Interchemie Ag
DE2915433A1 (de) * 1979-04-17 1980-10-30 Christensen Plantorgan Werk Verwendung von physiologisch vertraeglichen methyldonatoren
IL67768A0 (en) * 1982-03-01 1983-05-15 Pharmuka Lab Medicaments containing l-methionine
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
US4885157A (en) * 1987-02-13 1989-12-05 Fiaschetti Mary G Dermal cosmetic composition and applications therefor
DE3707127C2 (de) * 1987-03-05 1996-06-20 Zambon Spa Verwendung von Methionin zur Behandlung von Immun-Schwächeerkrankungen bei Virusinfektionen und/oder bei Tumorerkrankungen
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US4927850A (en) * 1988-04-08 1990-05-22 Bayless Robert K Antioxidant compositions and methods for ameliorating inflammatory symptoms of respiratory disease
US5055296A (en) * 1988-08-04 1991-10-08 Wagle Sudhakar S Method of treating chronic fatigue syndrome
IT1237519B (it) * 1989-11-27 1993-06-08 Impiego dell'acido guanidinacetico per indurre un incremento del contenuto muscolare di creatina
US5084482A (en) * 1990-04-10 1992-01-28 The Lithox Corporation Methods for inhibiting inflammatory ischemic, thrombotic and cholesterolemic disease response with methionine compounds
US5132113A (en) * 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids

Also Published As

Publication number Publication date
DE69233115D1 (de) 2003-08-07
AU2352792A (en) 1993-03-18
EP0532369A3 (US06312121-20011106-C00033.png) 1994-01-19
AP387A (en) 1995-07-31
AU666490B2 (en) 1996-02-15
EP0532369B1 (en) 2003-07-02
IL103152A0 (en) 1993-02-21
CA2078019A1 (en) 1993-03-14
AP9200426A0 (en) 1992-10-31
US5545670A (en) 1996-08-13
IL103152A (en) 1998-08-16
ATE244005T1 (de) 2003-07-15
EP0532369A2 (en) 1993-03-17
DE69233115T2 (de) 2004-05-06

Similar Documents

Publication Publication Date Title
CA2078019C (en) Substance or composition and uses thereof
ES2268048T3 (es) Composiciones para tratar enfermedades y sindromes animales que comprenden factor de transferencia.
JPS6212A (ja) メチルスルホニルメタンを含む食餌製品およびその使用
AU2002311871A1 (en) Compositions for treating animal diseases and syndromes
KR20070054739A (ko) 종합 경장 영양 조성물
US20090181923A1 (en) Method of increasing weight gain and reducing diarrhea morbidity, mortality and severity by stimulation of natural immune response, nutritional support of immune function and supplemental nutricines and probiotics
Oyawoye et al. Potential of chemical regulation of food intake and body weight of broiler breeder chicks
WO2016112552A1 (zh) 牛磺酸在预防和/或治疗由冠状病毒属和/或轮状病毒属病毒引发的疾病中的应用
CN105832759B (zh) 一种预防和/或治疗由冠状病毒属和/或轮状病毒属病毒引发的疾病的药物组合物
DK1776956T3 (en) An agent for the prevention and / or treatment of calcium deficiency
Abd-Allah et al. Influence of using flavomycin and propolis as feed additives on buffalo milk production, and growth performance and blood metabolites of suckling calves
Riva et al. The importance of early nutrition in broiler chickens: Hydrated gels enriched with nutrients, an innovative feeding system
RU2425674C2 (ru) Комплексный фармацевтический препарат
El Hadri et al. Glucose and electrolyte supplementation of drinking water improve the immune responses of poults with inanition
Archer Reducing stress in sheep by feeding the seaweed Ascophyllum nodosum
RU2813776C1 (ru) Способ лечения сальмонеллеза у молодняка крупного рогатого скота
US5215977A (en) Method for treating leg weakness in fowl
RU2231362C2 (ru) Способ профилактики болезней молодняка крупного рогатого скота
JPH0531527B2 (US06312121-20011106-C00033.png)
El-Kaiaty et al. EFFECTS OF EARLY HEAT STRESS ON SOME PHYSIOLOGICAL AND IMMUNOLOGICAL PARAMETERS IN TWO LOCAL STRAINS OF CHICKENS
AU2008200364A1 (en) Compositions for treating animal diseases and syndromes
RU2227026C1 (ru) Способ профилактики и лечения гепатодистрофии поросят
JPH01320956A (ja) 家蓄類の成長促進剤
UA132601U (uk) Застосування мінеролу та комплексу вітамінів для корекції мінерального обміну в овець з гепато-остеодистрофічним синдромом
JPH02503504A (ja) 食肉生産動物用ピルリマイシン成長促進剤

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed